Lokvančić, H. (2022) “ HER2 positive breast cancer and its treatment with trastuzumab, where are we now?”, Bioengineering Studies. Ilijaš, Bosnia, 3(2), pp. 35–43. doi: 10.37868/bes.v3i2.id239.